Question 1

What is the catalog number for Compound NP-012586?

Accepted Answer

The catalog number for Compound NP-012586 is T129988.

Question 2

Is Compound NP-012586 in stock?

Accepted Answer

Compound NP-012586 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound NP-012586?

Accepted Answer

Compound NP-012586 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound NP-012586?

Accepted Answer

Estimated delivery time for Compound NP-012586 is approximately 10 business day(s), depending on your location.

Question 5

Can this product be used in multiplex assays?

Accepted Answer

Multiplex compatibility depends on the specific product and detection panel. Contact our technical support team with details of your multiplex system for guidance before ordering.

Question 6

What happens if this product doesn’t perform as expected in my experiment?

Accepted Answer

Send us the catalogue number, product name, lot number, and a summary of your results. Our technical support team will investigate and, where needed, involve the manufacturer. This is covered under our guarantee provided the product was used before its expiry date and stored correctly.

Question 7

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Compound NP-012586

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

Chromogranin A / CHGA (Neuroendocrine Marker), CF405S conjugate, 0.1mg/mL

1-Chlorohexan-2-one

PIK3R6 (NM_001010855) Human Over-expression Lysate

CFTR Human Gene Knockout Kit (CRISPR)

PerCP/Cyanine5.5 Anti-Human CD20 Antibody[2H7]

PerCP/Cyanine5.5 Anti-Human CD20 Antibody[2H7]